Navigation Links
Multiple Sclerosis: new MRI contrast medium enables early diagnosis in animal model
Date:8/1/2008

In an animal model of multiple sclerosis (MS), neuroradiologists and neurologists of the University hospitals of Heidelberg and Wrzburg have been able to visualize inflammatory tissue damage, most of which had remained unrecognized up to now, with the aid of a new contrast medium, Gadofluorine M, in magnetic resonance imaging. The scientists have published their results in the online edition of the renowned medical journal Brain.

In particular at the early stage of the disease, drug treatment is effective. Up to now, how-ever, an early diagnosis is frequently not established with certainty, especially if no (or very few) inflammatory lesions are present on MRI. "With this new contrast medium, we were able to visualize five to ten times more foci of inflammation in comparison to conventional MRI images and contrast media", reports Professor Dr. Martin Bendszus, Medical Director of the Department of Neuroradiology at the University hospital of Heidelberg.

Previously unrecognized patches of demyelination visible in MRI

MS is a chronic inflammatory disease of the central nervous system of unknown cause. It usually begins in young adults, and women are affected more frequently. In Germany, ap-proximately 120,000 patients are afflicted. MS is characterized by multiple inflammatory le-sions in which nerve fibers lose their myelin sheath. These patches of demyelination cause neurological malfunctions that may regress upon remyelination. At later stages, MS may re-sult in a loss of nerve fibers, leading to irreversible damage and persistent neurological symptoms. MRI plays a crucial role in the early diagnosis of MS and monitoring of the dis-ease.

The scientists from Heidelberg and Wrzburg examined brains and spinal cords of animals at different stages of the disease with the new contrast medium and found significantly more inflammatory lesions than with conventional contrast media. Examinations of tissue sections f
'/>"/>

Contact: Dr. Martin Bendszus
martin_bendszus@med.uni-heidelberg.de
49-622-156-7566
University Hospital Heidelberg
Source:Eurekalert

Page: 1 2

Related biology news :

1. Fast AFM probes measure multiple properties of biomolecules or materials simultaneously
2. Potential new target for multiple sclerosis therapy
3. Multiple resource management is focus of new technical report
4. Multiple species of bacteria may cause trachoma: Implications for treatment
5. The power of multiples: Connecting wind farms can make a more reliable - and cheaper - power source
6. New magnetic separation technique might detect multiple pathogens at once
7. Israeli scientists identify: Genes that affect responses of multiple sclerosis patients to copaxone
8. For honey bee queens, multiple mating makes a difference
9. Emphasis on conifer forests places multiple species at risk
10. Nicotinic receptors may be important targets for treatment of multiple addictions
11. Diverse genetic abnormalities lead to NF-κB activation in multiple myeloma

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... contribute their abstracts to the World Congress ...st global meeting devoted to all aspects of osteop...e. The Congress will be held in Florence, Italy fr...an be submitted online at http://www.iofwco-ecceo..., 2010. , IOF and ESCEO are pleased to announce ...
(Date:11/20/2009)... single bacterial gene into yeast, researchers fro...s achieved three improvements in bioethanol produc...ol, less acetate and elimination of the major by-p...shed in the scientific journal Applied and Enviro...ol is made by the yeast Saccharomyces cerevisiae f...
(Date:11/20/2009)... Research Center (ERC) has been awarded a grant fr...methods of recovering and reusing the heat that wo...pression process in a carbon capture system. The g...n capture and sequestration, or storage (CCS), and... emitted into the atmosphere by coal-fired power p...
Breaking Biology News(10 mins):Special sessions announced for World Congress on Osteoporosis 2010 - IOF WCO - ECCEO10 2Special sessions announced for World Congress on Osteoporosis 2010 - IOF WCO - ECCEO10 3Delft breakthrough in bioethanol production from agricultural waste 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 3Pennsylvania Department of Health Continues Statewide Distribution H1N1 Vaccine 60014 1Pennsylvania Department of Health Continues Statewide Distribution H1N1 Vaccine 60014 2Steven Girgenti Irwin Lerner and Mel Rubin Voted Into Medical Advertising Hall of Fame 60009 1Steven Girgenti Irwin Lerner and Mel Rubin Voted Into Medical Advertising Hall of Fame 60009 2Media Advisory Oncolytics Biotech Inc to Present at BIO Investor Forum 2009 14580 1Media Advisory Oncolytics Biotech Inc to Present at BIO Investor Forum 2009 14580 2
...f allergy may be malfunction of the respiratory ep... and travel through the epithelium. Two studies by...ntly been published in two international biomedica...rgy and Clinical Immunology . , Research on the ...ding of aberrant immunoresponses. Only lately the ...
...sity in St. Louis have figured out the orientation...oring membrane in a photosynthetic bacterium, a ke...ynthesis. , Robert Blankenship, Ph.D., Markey Dis...rts & Sciences, led a team that for the first time... to verify the orientation. The team also included...
...research centers based in Woods Hole, Massachusett...ium, a new alliance that will bring their combined...ues facing society today and spawn scientific grow...chusetts. , The consortium comprises the Woods Ho...Oceanographic Institution (WHOI), and Woods Hole R...
Other Biology News:Malfunction of the respiratory epithelium is a cause of allergy? 2Orientation of antenna protein in photosynthetic bacteria described 2Orientation of antenna protein in photosynthetic bacteria described 33 Woods Hole scientific institutions forge alliance to address societal issues 23 Woods Hole scientific institutions forge alliance to address societal issues 3
(Date:11/20/2009)...FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasda...rcuit Court of Appeals reversed a U.S. District Co...pursue all of its claims against The Lash Group, s...al. CTI filed a complaint against The Lash Group,... for CTI,s product TRISENOX, in 2007 seeking $22.8...
(Date:11/19/2009)...- Danish Prince Joachim inaugurated the DONG Energ...rg, Denmark, on Wednesday, November 18. The facili...eration ethanol demonstration biorefineries. Genen...innovative process for converting straw to fuel. G...arket with commercial enzymes for converting cellu...
(Date:11/19/2009)...stCall/ -- NeoStem, Inc. (NYSE Amex: NBS ), annou...o its shareholders, discussing the Company,s acqui...ticals Holdings, Inc. (CHBP), an integrated bio-ph...c of China. The merger gives NeoStem a controlling...d., CHBP,s primary operating subsidiary and a prom...
(Date:11/19/2009)...Aegera Therapeutics Inc. announced today the dosin...udy of AEG35156, a targeted antisense therapeutic ...ications. ,, The study, entitled "An Open-Label...r of Apoptosis (XIAP) Antisense AEG35156 Given in ...in in AML Following Failure of a Single Standard D...
Breaking Biology Technology:Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2
...ct Suite by Adding Price Transparency, VERNON HIL...FirstCall/,-- Concuity, a healthcare division of T... contract management and revenue recovery technolo...nnounced its partnership with,Financial Healthcare...ution,for credible procedural price estimates that...
...WHRT ) World,Heart Corporation ("WorldHeart") toda...ation Agreement dated June 20, 2008 among WorldHea... ("WHI"), Abiomed, Inc.,("Abiomed"), Venrock Partn...k Entrepreneurs Fund V, L.P. (collectively, "Venro...ituations Cayman Fund, L.P., Special,Situations Pr...
...otech industry in the Midwest region, SAN FRANCIS...bioscience job board and life science career fair ...dwest(TM) Hotbed Campaign for the,bioscience indus...a,Missouri, Nebraska, Ohio and Wisconsin., The Bi...ademic,institutions from the biotechnology, pharma...
Other Biology Technology:Concuity Announces Partnership with Financial Healthcare Systems, LLC 2Concuity Announces Partnership with Financial Healthcare Systems, LLC 3Concuity Announces Partnership with Financial Healthcare Systems, LLC 4WorldHeart Enters into a Recapitalization Agreement and Receives Bridge Financing 2WorldHeart Enters into a Recapitalization Agreement and Receives Bridge Financing 3WorldHeart Enters into a Recapitalization Agreement and Receives Bridge Financing 4WorldHeart Enters into a Recapitalization Agreement and Receives Bridge Financing 5WorldHeart Enters into a Recapitalization Agreement and Receives Bridge Financing 6BioSpace Announces the 2008-2009 BioMidwest(TM) Hotbed Campaign 2
BacPlaque Agarose from Novagen
Mouse Anti-Human Histone H3, trimethyl (Lys27) Monoclonal Antibody, Unconjugated from Lake Placid Biologicals
Dithiothreitol, 1M from Upstate
Dithiothreitol, 1M from Upstate
Biology Products: